SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 171 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $4,856,000 | -82.4% | 437,864 | -75.1% | 0.00% | -82.6% |
| Q1 2015 | $27,531,000 | +16.8% | 1,755,818 | +13.3% | 0.02% | +15.0% |
| Q4 2014 | $23,575,000 | +67.4% | 1,549,973 | +18.7% | 0.02% | +53.8% |
| Q3 2014 | $14,086,000 | +7.3% | 1,306,092 | +51.9% | 0.01% | +8.3% |
| Q2 2014 | $13,129,000 | -7.4% | 859,760 | +9.7% | 0.01% | -7.7% |
| Q1 2014 | $14,176,000 | – | 784,077 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |